cresemba
basilea pharmaceutica deutschland gmbh - isavuconazole - aspergillosis - cresemba is indicated in adults for the treatment of:invasive aspergillosismucormycosis in patients for whom amphotericin b is inappropriateconsideration should be given to official guidance on the appropriate use of antifungal agents.
adaluzis 500 milligram pdr/conc/soln for infus
basilea medical ltd. c/o cox costello & horne limited - ceftobiprole medocaril sodium - pdr/conc/soln for infus - 500 milligram - other cephalosporins
cresemba 200mg powder for concentrate for solution for infusion vials
pfizer ltd - isavuconazonium sulfate - powder for solution for infusion - 200mg
cresemba 100mg capsules
pfizer ltd - isavuconazonium sulfate - capsule - 100mg
zevtera 500mg powder for concentrate for solution for infusion vials
correvio uk ltd - ceftobiprole medocaril sodium - powder for solution for infusion - 500mg
cresemba 100mg capsule
pfizer (malaysia) sdn. bhd. - isavuconazonium sulfate -
zelboraf 240mg comprimidos recubiertos
f. hoffmann-la roche s.a. basilea, suiza - vemurafenib - vemurafenib....240.00 mg.
medicamento
f. hoffmann-la roche s.a. basilea, suiza - vemurafenib - vemurafenib....240.00 mg.
posaconazol glenmark 40 mg/ml suspension zum einnehmen
zevtera 500 mg pulver für ein konzentrat zur herstellung einer infusionslösung